Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s receives EIR from USFDA for Srikakulam Plant

Date: 28-09-2017

Dr. Reddy’s Laboratories has received an Establishment Inspection Report (EIR) for its Formulation Srikakulam Plant (SEZ) Unit I, Andhra Pradesh from the US Food and Drug Administration (USFDA).

Recently, the company had received an EIR for its Formulation Srikakulam Plant (SEZ) Unit II, Andhra Pradesh from the USFDA.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.